ArticleACR open rheumatology2022

Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study.

Naomi J Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.